WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioxcel Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vimal MehtaCEO and President2026-05-2019,419$1.09
$21.11kSell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2026-05-206,560$1.08
$7.11kSell
Richard I. SteinhartChief Financial Officer2026-05-206,845$1.09
$7.43kSell
Frank YoccaChief Scientific Officer2026-05-206,845$1.09
$7.43kSell

1 of 1

BTAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTAI insiders and whales buy or sell their stock.

BTAI Shareholders

What type of owners hold Bioxcel Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vimal Mehta57.14%17,643,785$14.15MInsider
Bioxcel Holdings Inc56.89%17,566,750$14.09MInsider
Krishnan Nandabalan55.36%17,094,500$13.71MInsider
Rashmi Agarwal27.71%8,554,945$6.86MInsider
Vipin Agarwal27.71%8,554,945$6.86MInsider
Tarun K. Gupta27.69%8,550,396$6.86MInsider
Indu R. Gupta27.69%8,550,396$6.86MInsider
Suganthi Balasubramanian27.68%8,547,750$6.86MInsider
Anita Jain27.68%8,547,300$6.85MInsider
Diwakar Jain27.68%8,547,300$6.85MInsider

1 of 3

BTAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTAI2.67%97.33%Net SellingNet Selling
HOWL25.56%74.44%Net SellingNet Selling
IGC4.33%25.77%Net BuyingNet Buying
PSTV28.02%71.98%Net Buying
GRML8.03%15.43%Net BuyingNet Buying
View Top Biotech Stocks

Bioxcel Therapeutics Stock Ownership FAQ

Who owns Bioxcel Therapeutics?

Bioxcel Therapeutics (NASDAQ: BTAI) is owned by 17.62% institutional shareholders, 641.45% Bioxcel Therapeutics insiders, and 0.00% retail investors. Vimal Mehta is the largest individual Bioxcel Therapeutics shareholder, owning 17.64M shares representing 57.14% of the company. Vimal Mehta's Bioxcel Therapeutics shares are currently valued at $13.99M.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.